Recruiting Lymphoma Studies in Providence
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
The purpose of this study is to assess the safety and efficacy of AZD0486 administered as monotherapy or in combination with other anticancer agents in participants with hematological malignancies....
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone Lymphoma
BrUOG-401 is a prospective, single-arm, phase 2 trial of first-line therapy in adult patients with previously untreated FL or MZL. All patients will be assigned the same initial treatment plan, modifi...
About Lymphoma Clinical Trials in Providence
Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.
There are currently 2 lymphoma clinical trials recruiting participants in Providence, RI. These studies are seeking a combined 328 participants. Research is being sponsored by AstraZeneca, Brown University. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lymphoma Clinical Trials in Providence — FAQ
Are there lymphoma clinical trials in Providence?
Yes, there are 2 lymphoma clinical trials currently recruiting in Providence, RI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Providence?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Providence research site will contact you about next steps.
Are clinical trials in Providence free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Providence studies also compensate for your time and travel.
What lymphoma treatments are being tested?
The 2 active trials in Providence are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.
Data updated March 2, 2026 from ClinicalTrials.gov